PVCT
Price
$0.07
Change
+$0.01 (+16.67%)
Updated
Nov 18 closing price
Capitalization
29.08M
Intraday BUY SELL Signals
SLNCF
Price
$1.60
Change
-$0.20 (-11.11%)
Updated
Nov 4 closing price
Capitalization
226.72M
Intraday BUY SELL Signals
Interact to see
Advertisement

PVCT vs SLNCF

Header iconPVCT vs SLNCF Comparison
Open Charts PVCT vs SLNCFBanner chart's image
Provectus Biopharmaceuticals
Price$0.07
Change+$0.01 (+16.67%)
Volume$123.46K
Capitalization29.08M
Silence Therapeutics
Price$1.60
Change-$0.20 (-11.11%)
Volume$101
Capitalization226.72M
PVCT vs SLNCF Comparison Chart in %
PVCT
Daily Signal:
Gain/Loss:
SLNCF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PVCT vs. SLNCF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PVCT is a Hold and SLNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (PVCT: $0.07 vs. SLNCF: $1.60)
Brand notoriety: PVCT and SLNCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PVCT: 54% vs. SLNCF: 22%
Market capitalization -- PVCT: $29.31M vs. SLNCF: $226.72M
PVCT [@Biotechnology] is valued at $29.31M. SLNCF’s [@Biotechnology] market capitalization is $226.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PVCT’s FA Score shows that 1 FA rating(s) are green whileSLNCF’s FA Score has 1 green FA rating(s).

  • PVCT’s FA Score: 1 green, 4 red.
  • SLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, SLNCF is a better buy in the long-term than PVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PVCT’s TA Score shows that 6 TA indicator(s) are bullish while SLNCF’s TA Score has 2 bullish TA indicator(s).

  • PVCT’s TA Score: 6 bullish, 3 bearish.
  • SLNCF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, PVCT is a better buy in the short-term than SLNCF.

Price Growth

PVCT (@Biotechnology) experienced а +14.95% price change this week, while SLNCF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNCF($227M) has a higher market cap than PVCT($29.1M). SLNCF YTD gains are higher at: -39.048 vs. PVCT (-42.381). PVCT has higher annual earnings (EBITDA): -6.19M vs. SLNCF (-84.82M). SLNCF has more cash in the bank: 114M vs. PVCT (386K). SLNCF has less debt than PVCT: SLNCF (0) vs PVCT (2.51M). SLNCF has higher revenues than PVCT: SLNCF (27.2M) vs PVCT (0).
PVCTSLNCFPVCT / SLNCF
Capitalization29.1M227M13%
EBITDA-6.19M-84.82M7%
Gain YTD-42.381-39.048109%
P/E RatioN/AN/A-
Revenue027.2M-
Total Cash386K114M0%
Total Debt2.51M0-
FUNDAMENTALS RATINGS
PVCT vs SLNCF: Fundamental Ratings
PVCT
SLNCF
OUTLOOK RATING
1..100
734
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
8755
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
856

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PVCT's Valuation (4) in the null industry is in the same range as SLNCF (28). This means that PVCT’s stock grew similarly to SLNCF’s over the last 12 months.

PVCT's Profit vs Risk Rating (100) in the null industry is in the same range as SLNCF (100). This means that PVCT’s stock grew similarly to SLNCF’s over the last 12 months.

SLNCF's SMR Rating (97) in the null industry is in the same range as PVCT (100). This means that SLNCF’s stock grew similarly to PVCT’s over the last 12 months.

SLNCF's Price Growth Rating (55) in the null industry is in the same range as PVCT (87). This means that SLNCF’s stock grew similarly to PVCT’s over the last 12 months.

SLNCF's P/E Growth Rating (100) in the null industry is in the same range as PVCT (100). This means that SLNCF’s stock grew similarly to PVCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PVCTSLNCF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
50%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PVCT
Daily Signal:
Gain/Loss:
SLNCF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IBLLX36.00N/A
N/A
Transamerica Multi-Managed Balanced C
EEMGX10.15N/A
N/A
MFS Emerging Markets Equity Research R4
TPLNX18.16N/A
N/A
Timothy Plan Small Cap Value A
PWJBX33.60N/A
N/A
PGIM Jennison International Opps R2
MKGCX31.37-0.30
-0.95%
BlackRock Advantage Global K

PVCT and

Correlation & Price change

A.I.dvisor tells us that PVCT and LABFF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PVCT and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVCT
1D Price
Change %
PVCT100%
+13.44%
LABFF - PVCT
23%
Poorly correlated
N/A
RVPH - PVCT
20%
Poorly correlated
+9.77%
PPTDF - PVCT
17%
Poorly correlated
N/A
PTIX - PVCT
12%
Poorly correlated
+6.76%
PRRUF - PVCT
11%
Poorly correlated
N/A
More

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and ENVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and ENVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
ENVB - SLNCF
29%
Poorly correlated
+14.08%
RNXT - SLNCF
24%
Poorly correlated
-2.70%
QLGN - SLNCF
21%
Poorly correlated
+5.26%
SOLTF - SLNCF
9%
Poorly correlated
N/A
PVCT - SLNCF
8%
Poorly correlated
+13.44%
More